SCHEMBL3451872

SCHEMBL3451872

COc1ccc(C(CC(=O)O)C(=O)O)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.55
TNF P01375 1/20 0.54
POLB P06746 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
GAA P10253 2/20 0.51
ALDH1A1 P00352 1/20 0.51
LDHA P00338 1/20 0.51
AKR1C3 P42330 3/20 0.50
AKR1C2 P52895 3/20 0.50
AKR1C1 Q04828 1/20 0.50
PTGS1 P23219 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47
PPARA Q07869 1/20 0.47
BLM P54132 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TSHR P16473 1/20 0.46
PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3828059 0.87 AKR1C3 (0.65) ACHELDHAAKR1C3AKR1C2AKR1C1
SCHEMBL6366870 0.85 PPARG (0.57) ACHETNFPOLBL3MBTL1ALDH1A1
SCHEMBL6369033 0.85 PPARG (0.57) ACHETNFPOLBL3MBTL1ALDH1A1
SCHEMBL3959294 0.85 PPARG (0.57) ACHETNFPOLBL3MBTL1ALDH1A1
SCHEMBL9115691 0.85 TNF (0.58) ACHETNFPOLBGAAALDH1A1
SCHEMBL27524318 0.84 ACHE (0.55) ACHETNFPOLBL3MBTL1ALDH1A1
SCHEMBL7038489 0.84 ACHE (0.59) ACHETNFPOLBL3MBTL1GAA
SCHEMBL3828331 0.83 MTNR1A (0.48) ACHETNFPOLBALDH1A1LDHA
SCHEMBL9587784 0.83 ACHE (0.54) ACHETNFLDHAAKR1C3AKR1C2
SCHEMBL8771284 0.82 ACHE (0.56) ACHETNFPOLBL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820692-B2 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2010-10-26 US disclosed
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2009-11-05 US disclosed
EP-2045243-A1 TETRAHYDRO ISOQUINOLINE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF China Pharmaceutical University (CN) 2009-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof OPRK1, OPRD1, OPRL1 ACHE 312/4885TNF 1104/4885POLB 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.